Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 20, 2020

SELL
$130.51 - $196.01 $607,132 - $911,838
-4,652 Closed
0 $0
Q4 2019

Jan 17, 2020

BUY
$159.31 - $223.54 $405,762 - $569,356
2,547 Added 121.0%
4,652 $794,000
Q3 2019

Oct 09, 2019

SELL
$175.89 - $279.23 $356,177 - $565,440
-2,025 Reduced 49.03%
2,105 $374,000
Q2 2019

Jul 12, 2019

BUY
$250.96 - $284.94 $312,696 - $355,035
1,246 Added 43.2%
4,130 $1.08 Million
Q1 2019

Apr 12, 2019

BUY
$276.39 - $362.25 $579,037 - $758,913
2,095 Added 265.53%
2,884 $824,000
Q3 2018

Nov 13, 2018

SELL
$354.53 - $449.75 $10.4 Million - $13.1 Million
-29,232 Reduced 97.37%
789 $355,000
Q2 2018

Aug 02, 2018

BUY
$278.07 - $446.21 $8.35 Million - $13.4 Million
30,021 New
30,021 $2.78 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Altman Advisors, Inc. Portfolio

Follow Altman Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altman Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Altman Advisors, Inc. with notifications on news.